Drugs versus diets: Disillusions with dutch health care

Acta Biotheoretica

Volumn 49, Issue 2, 2001, Pages 125-140

  Van Der Steen, Wim J ^a   Ho, Vincent K Y ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Analgesic; Bias; Diet; Ecology; Fatty acid; Losec; Medication; Methodology; NSAID; Omeprazole; Pharmaceutical industry; Rheumatoid arthritis; Ulcer

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE;

COST BENEFIT ANALYSIS; DIET THERAPY; DRUG APPROVAL; DRUG COST; DRUG INDUSTRY; DRUG SURVEILLANCE PROGRAM; ECONOMICS; HUMAN; NETHERLANDS; PEPTIC ULCER; REVIEW; RHEUMATOID ARTHRITIS; TREATMENT OUTCOME;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; COST-BENEFIT ANALYSIS; DIET THERAPY; DRUG APPROVAL; DRUG COSTS; DRUG INDUSTRY; HUMANS; NETHERLANDS; OMEPRAZOLE; PEPTIC ULCER; TREATMENT OUTCOME;

EID: 0034961786     PISSN: 00015342     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010240129648     Document Type: Review

References (90)

1. Immunonutrition: The role of omega-3 fatty acids
2. Omega-3 fatty acids in rheumatoid arthritis: An overview
3. Addition of eicosapentaenoic acid to gamma-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans
4. N-3 polyunsaturated fatty acids and cytokine production in health and disease
5. Diet and arthritis
6. Prescription of non-steroidal anti-inflammatory agents and risk of iatrogenic adverse effects: A survey of 1072 French general practitioners
7. Diet and the prevention of cancer
8. Novel therapeutic approaches to gastric and duodenal ulcers: An update
9. Rioprostil in the acute and long-term treatment of peptic ulcers: A review
10. Hypothesis: Cis-unsaturated fatty acids as potential anti-peptic ulcer drugs
11. Marine and botanical lipids as immunomodulatory and therapeutic agents in the treatment of rheumatoid arthritis
12. Effects of three different fish oil formulations on Helicobacter pylori growth and viability: In vitro study
13. Dietary control of cancer
14. Fermented milk products are associated to ulcer disease. Results from a cross-sectional population study
15. Fats that Heal, Fats that Kill
16. Long-term follow-up and serologic assessment after triple therapy with omeprazole or lansoprazole of Helicobacter-associated duodenal ulcer
17. Effects of fish oil on gastric mucosal 6-keto-PGF1 alpha synthesis and ethanol-induced injury
18. The influence of diet and environment
19. What are we to conclude about psychoactive drugs? Scanning the major findings
20. Selection of drugs to treat gastro-oesophageal reflux disease: The role of drug interactions
21. Gastric acid, acid-suppressing drugs, and bacterial gastroenteritis: How much of a risk?
22. Candida overgrowth after treatment of duodenal ulcer; a comparison of cimetidine, famotidine, and omeprazole
23. Methodology and overt and hidden bias in reports in 196 double-blind trials of nonsteroid anti-inflammatory drugs in rheumatoid arthritis
24. Eicosanoids and essential fatty acid modulation in chronic disease and the chronic fatigue syndrome
25. Epidemiology of nonsteroidal anti-inflammatory drug-associated gastrointestinal injury
26. NSAIDs in The Netherlands: The View of a General Practitioner
27. Effect of fish oil on indometacin-induced gastric lesions in rats
28. Effect of acute administration of fish oil (omega-3 marine triglyceride) on gastric ulceration and secretion induced by various ulcerogenic and necrotizing agents in rats
29. Nutrition and immunity with emphasis on infection and autoimmune disease
30. Nonsteroidal anti-inflammatory drug gastropathy
31. What consideration should be given to Helicobacter pylori in treating nonsteroidal anti-inflammatory drug ulcers?
32. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: An overview of epidemiologic studies published in the 1990s
33. Dietary polyunsaturated fatty acids and depression: When cholesterol does not satisfy
34. Health benefits of docosahexaenoic acid
35. N-3 polyunsaturated fatty acids inhibit the antigen-presenting function of human monocytes
36. Comparative effect of palm vitamin E and ranitidine on the healing of ethanol-induced gastric lesions in rats
37. Psychiatric drugging: Forty years of pseudo-science, self-interest, and indifference to harm
38. A close and critical examination of how psychpharmacotherapy research is conducted
39. Risk factors for duodenal ulcer in north India
40. Dietary n-3 fatty acids and therapy for rheumatoid arthritis
41. Dietary polyunsaturated fatty acids and inflammatory mediator production
42. Assessment of the diet of patients with rheumatoid arthritis and osteoarthritis
43. Effects of modulation of inflammatory and immune parameters in patients with rheumatic and inflammatory disease receiving dietary supplementation of n-3 and n-6 fatty acids
44. N-3 fatty acid supplements in rheumatoid arthritis
45. The stress-protective effect of a new derivative of n-3-polyunsaturated fatty acids
46. Fatty acids and schizophrenia
47. Biochemical effects of a diet containing foods enriched with n-3 fatty acids
48. Pathophysiological effects of long-term acid suppression in man
49. Dietary intake and circulating vitamin levels of rheumatoid arthritis patients treated with methotrexate
50. Overuse of acid-suppressive therapy in hospitalized patients
51. New insights into the pathogenesis and treatment of rheumatoid arthritis
52. The design of clinical trials aimed at assessing the DC-ART properties of new molecules in rheumatoid arthritis
53. Assessment of long-term outcomes of rheumatoid arthritis. How choices of measures and study designs may lead to apparently different conclusions
54. Why randomized controlled clinical trials do not depict accurately long-term outcomes in rheumatoid arthritis: Some explanations and suggestions for future studies
55. The prevention of chronic NSAID induced upper gastrointestinal toxicity: A Cochrane collaboration metaanalysis of randomized controlled trials
56. Botanical lipids: Effects on inflammation, immune responses, and rheumatoid arthritis
57. Proton-pump inhibition and gastric giardiasis: A causal or casual association?
58. Inhibition of protein denaturation by fatty acids, bile salts and other natural substances: A new hypothesis for the mechanism of action of fish oil in rheumatic diseases
59. Severe nontyphoidial salmonellosis probably in relation with omeprazole treatment: Report of 2 cases
60. Emerging treatments for rheumatoid arthritis
61. The outcome of acute interstitial nephritis: Risk factors for the transition from acute to chronic interstitial nephritis
62. Actions and toxicity of nonsteroidal anti-inflammatory drugs
63. Essential fatty acids in health and chronic disease
64. Omeprazole fails to suppress up-regulation of gastric mucosal endothelin-converting enzyme-1 by Helicobacter pylori lipopolysaccharide
65. Esophageal candidiasis following omeprazole therapy: A report of two cases
66. Conflict of interest in the debate over calcium-channel antagonists
67. Omega-3 fatty acids and bipolar disorder: A review
68. Unnecessary prescribing of NSAIDs and the management of NSAID-related gastropathy in medical practice
69. Omeprazole and dry mouth
70. Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids
71. Inhibitory effect of polyunsaturated fatty acids on the growth of Helicobacter pylori: A possible explanation of the effect of diet on peptic ulceration
72. Clarification of the link between polyunsaturated fatty acids and Helicobacter pylori-associated duodenal ulcer disease: A dietary intervention study
73. Is Helicobacter pylori the primary cause of duodenal ulceration?
74. Protective effect offish oil against stress-induced gastric injury in rats
75. Forging links between philosophy, ethics, and the life sciences: A tale of disciplines and trenches
76. Bias in behavior genetics: An ecological perspective
77. Efficacy of fish oil concentrate in the treatment of rheaumatoid arthritis
78. Marked increase in gastric acid secretory capacity after omeprazole treatment
79. NSAIDs and the gastrointestinal mucosa